Dialysis dose and frequency

Nephrology Dialysis Transplantation

Volumn 20, Issue 2, 2005, Pages 285-296

  Locatelli, Francesco ^a   Buoncristiani, Umberto ^b   Canaud, Bernard ^c   Köhler, Hans ^d   Petitclerc, Thierry ^e   Zucchelli, Pietro ^f  

^a A MANZONI HOSPITAL   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c LAPEYRONIE HOSPITAL   (France)

^d SAARLAND UNIVERSITY   (Germany)

^e AURA   (France)

^f UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Daily dialysis; Dialysis adequacy; Dialysis dose; Kt V; Long slow nocturnal daily dialysis; Short daily dialysis; Survival; Urea kinetic model

Indexed keywords

CREATININE; UREA;

ARTICLE; BLOOD PRESSURE REGULATION; CALCULATION; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONCENTRATION RESPONSE; CREATININE CLEARANCE; DISEASE CONTROL; FREQUENCY ANALYSIS; HEALTH CARE DELIVERY; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; NUTRITIONAL STATUS; OUTCOMES RESEARCH; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; SOLUTE; UREA BLOOD LEVEL; UREMIA;

BIOLOGICAL MARKERS; HUMANS; PRACTICE GUIDELINES; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; TIME FACTORS; UREA;

EID: 14044253433     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh550     Document Type: Article

References (66)

1. Quinan J. The uremic theory. Maryland Med J 1880; 7: 193-198
2. Christison R. Observations on the variety of dropsy which depends on diseased kidneys. Edinburgh Med Surg J 1829; 32: 261-291
3. Fishberg A. Hypertension and Nephritis, 2nd edn. Lea and Febiger, Philadelphia, 1931; 619
4. Vanholder R, de Smet R, Bogeleere R, Hsu C, Ringoir S. The uremic syndrome. In: Jacobs C, Kjellstrand C, Koch K, Winchester J, eds. Replacement of Renal Function by Dialysis, 4th edn. Kluwer Academic Publishers, Dordrecht: 1996; 1-34
5. De Palma JR, Bolton CF, Baltzan MA, Baltzan RB. Adequate hemodialysis schedule. N Engl J Med 1971; 285: 353-354
6. Lowrie E, Laird N. Cooperative dialysis study. Kidney Int 1983; 23 [Suppl 13]: S1-S122
7. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019
8. Locatelli F, Marcelli D, Conte F et al. Patient selection affects end-stage renal disease outcome comparisons. Kidney Int 2000; 57 [Suppl 74]: S94-S99
9. Gotch FA, Sargent JA, Keen ML. Individualized, quantified dialysis therapy of uremia. Proc Clin Dial Transpl Forum 1974; 1: 27-37
10. Gotch FA. Kinetic modeling in hemodialysis. In: Nissenson AR, Gentile DE, Fine RN, eds. Clinical Dialysis, 2nd edn. Appleton and Lange, Norwalk CT: 1989; 18-46
11. Pedrini L, Zereik S, Rasmy S. Causes, kinetics and clinical implications of post hemodialysis urea rebound. Kidney Int 1998; 34: 817-824
12. Schneidtz D, van Stone JC, Daugirdas JT. A regional blood circulation alternative to in-series two-compartment urea kinetic modeling. ASAJO J 1994; 40: 667-673
13. Daugirdas JT, Depner TA, Gotch FA et al. Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 1997; 52: 1395-405
14. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213
15. Daugirdas JT, Schneditz D. Overestimation of hemodialysis dose depends on dialysis efficiency (K/V) by regional blood flow and conventional 2-pool urea kinetic analysis. ASAIO J 1995; 41: 719-724
16. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534
17. Keshaviah P. Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. Kidney Int 1993; 43 [Suppl 40]: S28-S38
18. Owen WF, Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001-1006
19. Hornberger JC. The haemodialysis prescription and quality-adjusted life expectancy. Renal Physicians Association Working Committee on Clinical Guidelines. J Am Soc Nephrol 1993; 4: 1004-1020
20. Collins AJ, Ma JZ, Umen A, Keshaviah P. Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994; 23: 272-82
21. Shinzato T, Nakai S, Akiba T et al. Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1997; 12: 884-888
22. Held PJ, Port FK, Wolfe RA et al. The dose of hemodialysis and patient mortality. Kidney Int 1996; 50: 550-556
23. McCullough KP, Young EW, Canaud BJ, Wolfe RA, Port FK, Held PJ. Delivered dialysis dose (DD) predicts mortality for hemodialysis patients (HD) in US and Europe. J Am Soc Nephrol 2000; 11: A1700
24. Churchill DN, Taylor DW, Keshaviah PR. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198-207
25. Maiorca R, Brunori G, Zubani R et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10: 2295-2305
26. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000. Am J Kidney Dis 2001; 37 [Suppl 1]: S7-S64
27. European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association. Section II. Haemodialysis adequacy. Nephrol Dial Transplant 2002; 17 [Suppl 7]: S16-S31
28. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000. Am J Kidney Dis 2001; 37 [Suppl 1]: S65-S136
29. Paniagua R, Amato D, Vonesh E et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-1320
30. Churchill DN. The ADEMEX study: make haste slowly. J Am Soc Nephrol 2002; 13: 1415-1418
31. Locatelli F. Dose of dialysis, convection and haemodialysis patients' outcome - what the HEMO Study doesn't tell us: the European viewpoint. Nephrol Dial Transplant 2003; 18: 1061-1065
32. Charra B, Calemard E, Ruffet M et al. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286-1291
33. Locatelli F, Manzoni C. Duration of dialysis sessions - was Hegel right? Nephrol Dial Transplant 1999; 14: 560-563
34. urea) is not the best dialysis dose parameter. Blood Purif 2000; 18: 286-294
35. Lowrie EG, Chertow GM, Lew NL, Lazarus JM, Owen WF. The urea [clearance × dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int 1999; 56: 729-737
36. Chertow GM, Owen WF, Lazarus JM, Lew NL, Lowrie EG. Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int 1999; 56: 1872-1878
37. Li Z, Lew NL, Lazarus JM, Lowrie EG. Comparing the urea reduction ratio and the urea product as outcome-based measures of hemodialysis dose. Am J Kidney Dis 2000; 35: 598-605
38. De Palma JR, Pecker EA, Mazwell MHA. New automatic coil dialyzer system for 'daily' dialysis. Proc Eur Dial Transplant Assoc 1969; 6: 26034
39. Bonomini V, Mioli V, Albertazzi A, Scolari P. Daily-dialysis programme: indications and results. Proc Eur Dial Transplant Assoc 1972; 9: 44-52
40. Fagugli RM, de Smet R, Buoncristiani U, Lameire N, Vanholder R. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. Am J Kidney Dis 2002; 40: 339-47
41. Woods JD, Port FK, Orzol S. Clinical and biochemical correlates of starting 'daily' hemodialysis. Kidney Int 1999; 55: 2467-2476
42. Fagugli RM, Reboldi G, Quintaliani G et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001; 38: 371-376
43. Chan CT, Harvey PJ, Picton P, Pierratos A, Miller JA, Floras JS. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 2003; 42: 925-931
44. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002; 61: 2235-2239
45. Chan C, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 2002; 17: 1518-1521
46. Klarenbach S, Heidenheim AP, Leitch R, Lindsay RM, Daily/Nocturnal Dialysis Study Group. Reduced requirement for erythropoietin with quotidian hemodialysis therapy. ASAIO J 2002; 48: 57-61
47. Rao M, Muirhead N, Klarenbach S et al. Management of anaemia with quotidian hemodialysis. Am J Kidney Dis 2003; 42 [Suppl 1]: S18-S23
48. Al-Hejaili F, Kortas C, Leitch R et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003; 14: 2322-2328
49. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617
50. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138
51. Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252
52. Galland R, Traeger J, Arkouche W, Cleaud C, Delawari E, Fouque D. Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int 2001; 60: 1555-1560
53. Fagugli RM, Vanholder R, de Smet R et al. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis. Int J Artif Organs 2001; 24: 256-262
54. Floridi A, Antolini F, Galli F, Fagugli RM, Floridi E, Buoncristiani U. Daily haemodialysis improves indices of protein glycation. Nephrol Dial Transplant 2002; 17: 871-878
55. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18: 1272-1280
56. Heidenheim AP, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003; 42 [Suppl]: S36-S41
57. Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344: 102-107
58. Hanly PJ, Gabor JY, Chan C, Pierratos A. Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am J Kidney Dis 2003; 41: 403-410
59. Zoccali C, Mallamaci F, Tripepi G. Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. J Am Soc Nephrol 2002; 13: 729-733
60. Maduell F, Navarro V, Torregrosa E et al. Changes from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 2003; 64: 305-313
61. Williams AW, Chebrolu SB, Ing TS et al. Early clinical, quality-of-life, and biochemical changes of 'daily hemodialysis' (6 dialyses per week). Am J Kidney Dis 2004; 43: 90-102
62. Quintaliani G, Buoncristiani U, Fagugli R et al. Survival of vascular access during daily and three times a week hemodialysis. Clin Nephrol 2000; 53: 372-377
63. Pierratos A. Nocturnal home haemodialysis: an update on a 5-year experience. Nephrol Dial Transplantation 1999; 14: 2835-2840
64. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003; 42: 1020-1035
65. Mohr PE. The economics of daily dialysis. Adv Ren Replace Ther 2001; 8: 273-279
66. McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 2002; 62: 2216-2222